Abstract
Drug-related osteonecrosis of the jaw (MRONJ) is an adverse effect caused by the use of antiresorptive or antiangiogenic drugs. Its etiopathology, as well as its prevention, control, and cure, remain a challenge today. Local therapies play a key role in controlling these cases, such as ozone therapy administered in an oil vehicle. In addition, plasma concentrates have been widely used in …